Teva Pharmaceutical Industries Total Long Term Liabilities 2010-2024 | TEVA

Teva Pharmaceutical Industries total long term liabilities for the quarter ending December 31, 2024 were $21.149B, a 8.47% decline year-over-year.

  • Teva Pharmaceutical Industries total long term liabilities for 2024 were $21.149B, a 8.47% decline from 2023.
  • Teva Pharmaceutical Industries total long term liabilities for 2023 were $23.106B, a 3.5% decline from 2022.
  • Teva Pharmaceutical Industries total long term liabilities for 2022 were $23.945B, a 5.71% decline from 2021.

Teva Pharmaceutical Industries Total Long Term Liabilities 2010-2024 | TEVA

  • Teva Pharmaceutical Industries total long term liabilities for 2024 were $21.149B, a 8.47% decline from 2023.
  • Teva Pharmaceutical Industries total long term liabilities for 2023 were $23.106B, a 3.5% decline from 2022.
  • Teva Pharmaceutical Industries total long term liabilities for 2022 were $23.945B, a 5.71% decline from 2021.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M